Arcturus Therapeutics' SWOT analysis: mRNA innovator's stock faces pivotal year
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $446.4 million specializing in mRNA therapeutics and vaccines, stands at a ...
Arcturus: Downgrading As mRNA Promise Meets Market Reality
Arcturus Therapeutics Holdings Inc. stock is down 46% since Sept. 2023 coverage; mRNA sector faces headwinds with public ...
Alberta MLA wants province to follow through on COVID-19 report recommendations 'immediately'
Lougheed, said the findings of the report were “shocking” and that the information it presents to the public is “long overdue ...
News Medical on MSN10h
BEND lipids revolutionize mRNA delivery and gene-editing
Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking system and its counterpart on the station.
Escaping the endosome: BEND lipids improve LNP mRNA delivery and gene editing
Every time a shuttle docks with the International Space Station (ISS), a delicate dance unfolds between the shuttle's docking ...
The Idaho Press-Tribune3h
A bill to put 10-year pause on certain vaccines, "gene therapy" products introduced
Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause certain types of vaccines that were used for some of ...